Abbott Laboratories has grown revenue 2.8% a year over three years and 3.9% a year over five, with earnings per share compounding at 2.9%. Revenue growth, 3-year annual rate: +2.8% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +3.9%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +2.9%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

ABTAbbott Laboratories

HealthcareUSD

$114.10

$82.5652 weeks$134.49

Is it growing?

Is ABT growing?

Abbott Laboratories has grown revenue 2.8% a year over three years and 3.9% a year over five, with earnings per share compounding at 2.9%.

+2.8%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +3.9%
Revenue growth, 5-year rate · +2.8% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +2.9%
Earnings per share, 3-year rate · revenue +2.8% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed